According to
the study, ‘United Kingdom Hip Reconstruction Market
Outlook To 2025’, few
dominant players in the United Kingdom Hip Reconstruction Market are Zimmer
Biomet Holdings Inc, DePuy Synthes Inc, Stryker Corp, Corin Group PLC, Smith
& Nephew Plc.
The increasing number of the elderly people especially in the developed
countries has raised the demand for healthcare systems all around the globe.
Hip reconstruction is prominently present in the people aged above 60 years of
age. Most of the people who undergo this surgery claim this to be a cost
effective surgery considering the end stage of the condition. The changing
level and nature of demand from the elderly to young people has resulted in a
supply deficiency. Initiative by government and NGOs to maintain a national
waiting list in the United Kingdom has reduced the potential threat of a long
waiting list. With limited funding, it has become a prerequisite for companies
to keep a close track of the demand in order to decide on the target market
both in terms of age groups and geography.
Most of the pharmaceutical industry around the world is dominated by only
a few players and is highly concentrated. Similar is the case with United
Kingdom’s hip reconstruction industry which is dominated by international
players with deep pockets. Uncertainty is a key factor that is prevalent in the
United Kingdom hip reconstruction market. Research and development teams are
constantly coming up with new technologies which make the entire market
dynamic. Also, since newer medicines are being developed that claim to cure
this condition, it puts this market in a dangerous position. United Kingdom
indentifies small number of companies supplying wide varieties of brands and
products in the market which is dominated by Zimmer and Stryker Osteonics. The
Hip Prosthesis in the United Kingdom forms only a small portion of the global
industry. JRI orthopedics is an implant manufacturer in United Kingdom which is
wholly owned by British Furlong Research Charitable Foundation. This company is
present only in UK market, manufacturing implants only. There are two variants
of hip reconstruction material available in the market and these are cemented
and cement less which has high degree of substitutability. National Health
Service in UK is considered to be the monopolist buyer however, recent trend
has showcased that hospitals are also procuring implants directly from the
manufacturer. Due to the supply
deficiency that is present in the market, many patients are being denied access
to the treatment which significantly reduces their experience of undergoing the
procedure.
The entire UK hip reconstruction market is expected to have a steady but
slow growth in the coming years due to certain key factors. This includes high
concentration in the market coupled with research and development in oral
medication to treat this condition entirely and also due to the supply deficiency
that is present in the market. This has also created problems for the new
entrants in the market. If companies wish to enter this industry in the United
Kingdom, they need to come up with new technology that is not only is cost
effective but also which has the potential to improve patient’s post treatment
experience.
To know more, click on the link below:
Related Reports
+91-9015378249
